Harmony Change To Operating Activities from 2010 to 2026

HRMY Stock  USD 38.55  0.68  1.80%   
Harmony Biosciences Change To Operating Activities yearly trend continues to be fairly stable with very little volatility. Change To Operating Activities will likely drop to about 11.1 M in 2026. During the period from 2010 to 2026, Harmony Biosciences Change To Operating Activities regression line of annual values had r-squared of  0.75 and arithmetic mean of  6,208,084. View All Fundamentals
 
Change To Operating Activities  
First Reported
2010-12-31
Previous Quarter
14.8 M
Current Value
11.1 M
Quarterly Volatility
6.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 55.9 M, Net Interest Income of 988.5 K or Depreciation And Amortization of 16.4 M, as well as many indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0 or PTB Ratio of 2.81. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Harmony Stock
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Change To Operating Activities Growth Pattern

Below is the plot of the Change To Operating Activities of Harmony Biosciences Holdings over the last few years. It is Harmony Biosciences' Change To Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Change To Operating Activities10 Years Trend
Slightly volatile
   Change To Operating Activities   
       Timeline  

Harmony Change To Operating Activities Regression Statistics

Arithmetic Mean6,208,084
Geometric Mean2,142,754
Coefficient Of Variation103.88
Mean Deviation6,101,030
Median446,000
Standard Deviation6,449,183
Sample Variance41.6T
Range15M
R-Value0.86
Mean Square Error11.3T
R-Squared0.75
Slope1,102,999
Total Sum of Squares665.5T

Harmony Change To Operating Activities History

202611.1 M
202514.8 M
202212.9 M
202115.5 M
202012.8 M
20198.7 M

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Change To Operating Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Operating Activities14.8 M11.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.